Horizon Two
Horizon Two: HR NDMM (MMRC-100)
Arms / Cohorts
Experimental:Induction, Consolidation, and Maintenance Therapy Combining Linvoseltamab and Triplet Therapy
Accepting patients
Active Comparator:Control Arm: Isa-KRd with Autologous Stem Cell Transplant
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.